Precigen share price logo

Precigen

NASDAQ: PGEN

Mid Cap

$6.95

-0.24

(-3.34%)

as on

Precigen Stock Performance

as on August 29, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $6.92
    $7.19
    downward going graph

    0.43%

    Downside

    3.45%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.99
    $7.72
    downward going graph

    56.98%

    Downside

    11.01%

    Upside

    downward going graph

Precigen share price movements today

Previous Close
$7.19
Open
$7.13
Volume
2.2M
Market Cap
$2.7B
Day's Low - High
$6.92 - $7.19
52 Week Low - High
$2.99 - $7.72

Precigen Historical Returns

1 Month Return
+ 30.02 %
3 Month Return
+ 59.42 %
1 Year Return
+ 58.02 %
3 Year Return
+ 318.02 %
5 Year Return
+ 19.83 %

Precigen Stock Fundamentals & Key Indicators

Check Precigen market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.7B

EPS (TTM)

0.2203

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-35.4M

Revenue (TTM)

85.7M

Profit Margin

-183.98%

Return On Equity TTM

-837.08%

Precigen vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Precigen with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Precigen image
Precigen
BUY$2.7B19.83%NA-183.98%NA
Revolution Medicines image
Revolution Medicines
BUY$46.2B675.69%NA0.00%NA
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
BUY$138.7B173.88%31.9286.04%NA
Moderna image
Moderna
BUY$59.7B-62.65%-7.98-12.57%NA
Regeneron image
Regeneron
BUY$85.8B21.77%19.984.86%0.44%

Stock Returns calculator for Precigen Stock including INR - Dollar returns

The Precigen stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Precigen investment value today

Current value as on today

₹1,65,555

Returns

₹65,555

(+65.56%)

Returns from Precigen Stock

₹52,747 (+52.75%)

Dollar Impact

₹12,808 (+12.81%)

Analyst Recommendation on Precigen Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Precigen. Average target price of $14.5

Precigen Share Price Target

Get share price movements and forecasts by analysts on Precigen.

What analysts predicted

52.07%UPSIDE

Target Price

$14.5

Current Price

$6.95

Analyzed by

1 Analysts

Target

$14.50

Precigen target price $14.5, a slight upside of 52.07% compared to current price of $6.95. According to 1 analysts rating.

Indian Investors' Interest in Precigen Stock

Search interest for Precigen Stock has decreased by -39% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-39% versus previous 30 day period

Precigen Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
1
0
0
1
1
0
2
4
23
54
Gross Profit
0
0
0
0
0
0
1
2
20
52
Operating Income
-24
-60
-21
-28
-22
-31
-34
-21
-5
22
EBITDA
-22
-58
-23
-19
-53
-27
-144
-19
-3
23
Interest Expense
0
0
0
0
0
-
0
2
2
2
Depreciation
1
1
0
0
0
0
0
1
1
1
Income Before Tax
-23
-60
-23
-19
-54
-26
-146
-23
-7
20
Income Tax Expense
0
-1
0
0
0
0
179
0
-
-
Net Income
-23
-58
-23
-19
-54
-26
-146
-23
-7
20
Net Profit Margin
-2228.92%
-8199.72%
-2516.05%
-1657.73%
-4038.26%
-3112.38%
-5008.35%
-514.85%
-34.10%
36.51%

Precigen Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
190
230
160
31
31
14
26
6
3
9
Gross Profit
129
168
97
26
-12
-39
20
0
0
3
Operating Income
-125
-137
-505
-86
-86
-91
-75
-99
-135
-106
EBITDA
-168
-97
-349
-68
-67
-77
-62
-89
-123
-243
Interest Expense
0
0
8
18
18
18
6
0
0
3
Depreciation
-
31
33
24
17
13
10
6
4
3
Income Before Tax
-194
-129
-536
-104
-104
-110
-79
-96
-128
-250
Income Tax Expense
-3
-2
-21
0
0
0
0
0
-1
0
Net Income
-186
-117
-509
-170
-170
-92
28
-95
-126
-250
Net Profit Margin
-97.74%
-50.66%
-317.20%
-533.01%
-533.01%
-646.01%
105.23%
-1540.63%
-3216.18%
-2588.21%

Precigen Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-58
-23
-19
-54
-26
-146
-23
-7
20
Operating Cash Flow
-23
-22
-8
-16
-18
-29
-23
-43
-17
Investing Cash Flow
14
5
-65
-6
28
-63
39
20
26
Financing Cash Flow
0
32
78
0
-1
93
0
0
0
Change in Cash
-8
15
4
-23
7
0
15
-22
8

Precigen Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-126
-514
-170
-170
-92
28
-95
-126
-250
Operating Cash Flow
-104
-124
-77
-77
-55
-65
-66
-68
-87
Investing Cash Flow
104
-151
27
27
-74
226
-3
-20
-1
Financing Cash Flow
4
309
32
32
121
-155
29
110
90
Change in Cash
5
34
-16
-16
-8
5
-40
21
0

Mutual Funds that own Precigen Stock

Check out the Mutual Funds with significant holdings in Precigen.

Funds
Holdings
Shares Held
Trust for Advised Portfolios
6.70325%
24000000
VANGUARD INDEX FUNDS
1.949692%
6980585
Fidelity Securities Fund
0.545327%
1952463
Fidelity Salem Street Trust
0.544796%
1950564
Fidelity Concord Street Trust
0.524626%
1878348
See all

Global Institutional Holdings in Precigen

Funds
Holdings
Vanguard
2.8%
iShares
2.72%
SPDR
2.45%
First Trust
0.72%
Michael Rockefeller
0.39%
See all

Precigen News & Key Events

  • img

    Today's Timeline - 14 November

    Fri, 10:31 AM

    -

    Precigen receives FDA approval for Papsius, achieving a 51% complete response rate in RRP treatment.

Insights on Precigen

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, -146.34M → 20.07M (in $), with an average increase of 286.2% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, PGEN has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, PGEN stock has moved up by 60.1%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 5 quarters, 856.0K → 54.97M (in $), with an average increase of 61.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 472.8% return, outperforming this stock by 418.7%

About Precigen

Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases. The company offers therapeutic platforms consisting of AdenoVerse platform, which utilizes a library of proprietary adenovectors for gene delivery of therapeutic effectors, immunomodulators, and vaccine antigen; and UltraCAR-T to provide chimeric antigen receptor T cell therapies for cancer patients. It also develops programs based on the UltraCAR-T platform, including PRGN-3005 in Phase 1/1b clinical trial to treat advanced ovarian, fallopian tube, or primary peritoneal cancer; PRGN-3006 in Phase 1b trial for patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndromes; and PRGN-3007 in Phase 1/1b trial for the treatment of advanced receptor tyrosine kinase-like orphan receptor 1-positive, hematologic, and solid tumors. In addition, the company is developing programs based on the AdenoVerse immunotherapy platform comprising PRGN-2009 in Phase 2 trial for patients with HPV+ solid tumors; and PRGN-2012 in Phase ½ trial to treat recurrent respiratory papillomatosis. Further, it provides UltraPorator, a proprietary electroporation device. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in February 2020. Precigen, Inc. was founded in 1998 and is headquartered in Germantown, Maryland.
OrganisationPrecigen
Headquarters20374 Seneca Meadows Parkway, Germantown, MD, United States, 20876
IndustryBiotechnology
CEODr. Helen Sabzevari MPH, Ph.D.
E-voting on sharesClick here to vote

Key Management of Precigen

Name

Title

Dr. Bryan T. Butman Ph.D.

Senior VP & Head of CMC

Dr. Amy R. Lankford Ph.D.

Senior VP & Head of Clinical Operations and Regulatory Affairs

Mr. Rutul R. Shah

Chief Operating Officer

Mr. Phil Tennant

Chief Commercial Officer

Mr. Steven M. Harasym

VP & Head of Investor Relations

Dr. Douglas E. Brough Ph.D.

Senior VP & Head of Research

Mr. Randal J. Kirk J.D.

Executive Chairman

Dr. Helen Sabzevari MPH, Ph.D.

President, CEO & Director

Mr. Harry Thomasian Jr.

Chief Financial Officer

Mr. Donald P. Lehr J.D., Ph.D.

Chief Legal Officer & Corporate Secretary

FAQs

What is Precigen share price today?

Precigen share price today is $6.95 as on at the close of the market. Precigen share today touched a day high of $7.19 and a low of $6.92.

What is the 52 week high and 52 week low for Precigen share?

Precigen share touched a 52 week high of $7.72 on and a 52 week low of $2.99 on . Precigen stock price today i.e. is closed at $6.95,which is 9.92% down from its 52 week high and 132.44% up from its 52 week low.

What is Precigen's market capitalisation today?

Precigen market capitalisation is $0.00T as on .

How to invest in Precigen Stock (PGEN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Precigen on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Precigen Shares that will get you 0.2158 shares as per Precigen share price of $6.95 per share as on August 29, 2026 at 8:46 am IST.

What is the minimum amount required to buy Precigen Stock (PGEN) from India?

Indian investors can start investing in Precigen (PGEN) shares with as little as ₹95.38 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.80 in Precigen stock (as per the Rupee-Dollar exchange rate as on ). Based on Precigen share’s latest price of $6.95 as on August 29, 2026 at 8:46 am IST, you will get 1.4388 shares of Precigen. Learn more about fractional shares .

What are the returns that Precigen has given to Indian investors in the last 5 years?

Precigen stock has given 19.83% share price returns and 30.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?